Anicom Holdings, Inc.

8715.T
Insurance - Property & Casualty
2026/11/20 13:29 Updated
Market Cap: $466.6M (¥74.1B)
Stock Price: $6.41 (¥1,017)
Exchange Rate: 1 USD = ¥158.73

Notice Regarding Monthly Operational Parameters for November 2026

Monthly operational parameters including net earned premiums, number of policies in force, average persistency rate, Pet Kenkatsu application numbers, number of patents held, and JARVIS Tokyo revenue are disclosed as monthly data for fiscal 2026. Monthly indicators from October onward are listed, and the schedule for fiscal reporting months is also mentioned.

Importance:
Page Updated: November 20, 2026
IR Disclosure Date: November 20, 2026

Key Figures

  • Net Earned Premiums: Range of monthly data (e.g., April May ... September) unknown
  • Number of Policies in Force: 1,397,826 cases → 1,433,091 cases (increase year-over-year)
  • Average Persistency Rate: 88.5% → 88.8% (slight increase)
  • Pet Kenkatsu Application Numbers: April 22,227 cases → September 16,701 cases (fluctuating)
  • Number of Patents Held: 27 cases → 32 cases (increase)

AI要約

Overview of Monthly Parameters

This document discloses the monthly operational parameters for fiscal 2026, presenting key monthly indicators such as net earned premiums, number of policies in force, average persistency rate, Pet Kenkatsu application numbers, number of patents held, and JARVIS Tokyo revenue. It summarizes trends from April through September, providing comparisons with the prior period and the latest actuals. Unlike a financial summary, this information is provided to help track monthly progress.

Future Disclosure Schedule and Key Points

For reference, monthly parameter disclosures are scheduled to be released around mid-month each month, and in fiscal reporting months (June, September, December, March) disclosures will be made on the same day as quarterly financial announcements. In particular, trends in the number of policies in force and persistency rate are notable because they affect long-term customer retention and revenue stability. The increase in the number of patents held may also contribute to future strategy as part of promoting Bio Insurtech.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Anicom Holdings, Inc.

Company overview · Stock price · Financial data · All IR

View company page →